Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

NCT02355509 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Glucose Intolerance
Postprandial Hyperglycemia
Cardiovascular Risk Factor

Interventions

DRUG: Acarbose
DRUG: Placebo

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran